Arcellx (ACLX) Shares Outstanding (Diluted Average) (2021 - 2025)

Arcellx's quarterly Shares Outstanding (Diluted Average) came in at $56.3 million in Q4 2025, up 5.11% year-on-year from $53.6 million in Q4 2024, and little changed quarter-over-quarter from $56.6 million in Q3 2025.

Arcellx has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $56.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 5.11% year-over-year to $56.3 million; the trailing twelve-month figure through Dec 2025 stood at $56.3 million (up 5.11% YoY), and the FY2025 full-year result was $56.3 million, up 5.11% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 stood at $56.3 million, roughly flat from $56.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $56.6 million in Q3 2025, with the low at $337302.0 in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $37.4 million, with a median of $47.6 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Diluted Average) jumped 8044.59% in 2022 and increased 4.74% in 2025.
  • Tracing ACLX's Shares Outstanding (Diluted Average) over 5 years: stood at $446379.0 in 2021, then jumped by 8044.59% to $36.4 million in 2022, then jumped by 32.2% to $48.1 million in 2023, then rose by 11.45% to $53.6 million in 2024, then advanced by 5.11% to $56.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $56.3 million (Q4 2025), $56.6 million (Q3 2025), and $56.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 56.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 56.31 Mn
Sep 30, 2025 56.59 Mn
Jun 30, 2025 56.22 Mn
Mar 31, 2025 55.26 Mn
Dec 31, 2024 53.57 Mn
Sep 30, 2024 53.37 Mn
Jun 30, 2024 53.52 Mn
Mar 31, 2024 52.76 Mn
Dec 31, 2023 48.06 Mn
Sep 30, 2023 47.78 Mn
Jun 30, 2023 47.44 Mn
Mar 31, 2023 46.77 Mn
Dec 31, 2022 36.36 Mn
Sep 30, 2022 33.81 Mn
Jun 30, 2022 28.73 Mn
Mar 31, 2022 20.76 Mn
Dec 31, 2021 446,379.00
Sep 30, 2021 422,825.00
Jun 30, 2021 437,258.00
Mar 31, 2021 337,302.00